EW240719C80000
- 12.57
- 0.000.00%
Edwards Lifesciences Newsroom
PROPEL Fund Deploys $25 Million to Promote Health, Equity and Economic Growth in Underserved Communities
CHICAGO--(BUSINESS WIRE)--Broadstreet Impact Services announced today that it has fully deployed the $25 million PROPEL Fund to finance economic development projects that promote health, wealth and op
$1000 Invested In This Stock 20 Years Ago Would Be Worth $33,000 Today
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.86% on an annualized basis producing an average annual return of 19.18%. Currently, Edwards Lifesciences has a m
A Look Into Edwards Lifesciences' (NYSE:EW) Impressive Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in con
AM Best Assigns Performance Assessment to Edward William Insurance Services LLC
AMSTERDAM--(BUSINESS WIRE)--#insurance--AM Best has assigned a Performance Assessment (assessment) of PA-4 (Fair) to Edward William Insurance Services LLC (EW) (United States). The outlook assigned to
The Analyst Landscape: 13 Takes On Edwards Lifesciences
13 analysts have expressed a variety of opinions on Edwards Lifesciences (NYSE:EW) over the past quarter, offering a diverse set of opinions from bullish to bearish.The following table encapsulates th
Deutsche Bank's Fresh Money List for 3Q
Edwards Lifesciences Is Maintained at In-Line by Evercore ISI Group
Edwards Lifesciences Is Maintained at In-Line by Evercore ISI Group
Edwards Lifesciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 1.51% Evercore ISI Group $89 → $91 Maintains In-Line 05/30/2024 19.35% Goldman Sachs → $107 Ini
Evercore Maintains Edwards Lifesciences(EW.US) With Hold Rating, Raises Target Price to $91
Evercore analyst Vijay Kumar maintains $Edwards Lifesciences(EW.US)$ with a hold rating, and adjusts the target price from $89 to $91.According to TipRanks data, the analyst has a success rate of 47.4
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating
Edwards Lifesciences (EW) has an average outperform rating and a price target range of $70 to $107, according to analysts polled by Capital IQ. Price: 91.00, Change: +0.75, Percent Change: +0.83
Deutsche Numis Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $103
Deutsche Numis analyst Pito Chickering maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and maintains the target price at $103.According to TipRanks data, the analyst has a success rate of 5
Is Edwards Lifesciences Corp (NYSE:EW) the Best Medical Stock to Buy in 2024?
J.P. Morgan Maintains Edwards Lifesciences(EW.US) With Buy Rating
J.P. Morgan analyst Robbie Marcus maintains $Edwards Lifesciences(EW.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 54.6% and a total average return of 11.6% over
Express News | CNBC Halftime Report Final Trades: Edwards Lifesciences, American Tower, Transdigm
The Best of Breed Global Stocks for 3Q2024 - BofA
BofA Securities analysts listed the best of breed global stocks for the third quarter of the year.
Unusual Options Activity: DDOG, BABA and Others Attract Market Bets, DDOG V/OI Ratio Reaches 162.5
EST Jun 21st Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend
Peering Into Edwards Lifesciences's Recent Short Interest
Edwards Lifesciences's (NYSE:EW) short percent of float has risen 3.73% since its last report. The company recently reported that it has 8.29 million shares sold short, which is 1.39% of all regular s
BofA Securities Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $105
BofA Securities analyst Travis Steed maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and maintains the target price at $105.According to TipRanks data, the analyst has a success rate of 61.
BTIG Maintains Edwards Lifesciences(EW.US) With Hold Rating
BTIG analyst Marie Thibault maintains $Edwards Lifesciences(EW.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 33.7% and a total average return of -1.2% over the
Edwards Lifesciences(EW.US) Officer Sells US$48,150 in Common Stock
$Edwards Lifesciences(EW.US)$ Officer Lippis Daniel J. sold 535 shares of common stock on Jun 20, 2024 at an average price of $90 for a total value of $48,150.Source: Announcement What is statement of